CI vs NPCE · P/E 2.4, rev $274.90B vs rev $79.9M
Cigna Corp (CI) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the CI and NPCE stock pages for the full models.
Not investment advice.